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List of abbreviations 
CI = Confidence interval 
CVD = Cardiovascular disease 
ECG = Electrocardiography 
ECGA = Electrocardiography Abnormality 
FRI = Framingham Risk Index 
FRS = Framingham Risk Score 
HR= Hazard Ratio 
ICD = International classification of diseases 
MC = The Minnesota Code Classification System for Electrocardiographic Findings  
MI = Myocardial infarction 
OR= Odds ratio 
Pseudo-R2 = Calculation of how much of the outcome variation is explained by the model. 
P-Value = Probability value  
QRS-complex = An ECG pattern that symbolizes the depolarization of ventricles  
QTc= An ECG pattern that measures the time between ventricles depolarization and ventricles 
repolarization corrected for pulse rate. 
RR=Relative Risk 
STJ= ST-junction = An ECG pattern symbolizes phase 2 of ventricular repolarization. 
T-Wave = An ECG pattern symbolizes phase 3 of ventricular repolarization 
USPSTF = United States’ Preventive Services Task Force 
WHO=World Health Organization 
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Abstract 
Background: The Coeur Project started in 1992 as a joint medical project between two 
automotive companies, one located in Sweden (the Volvo Corporation) and one located in France 
(Renault Automotive Group). The original design of the Coeur study had 3 steps. In 1993, 
baseline data was collected from 1,000 randomly selected men aged 45-50 years from each of the 
two enterprises.  In 1995, a second step involved special investigations of 100 high and 100 low 
risk individuals according to Framingham risk index. These included diet, ultrasonographic and 
blood viscosimetry investigations. All participants underwent new examinations, In a third step, 
1998, all baseline participants were offered a full nurse-led health assessment to evaluate 
cardiovascular end-points after five years. The objective of the fourth step of the longitudinal 
cohort study was to investigate associations between various potential risk factors and death or 
myocardial infarctions (MI) during the following 25 years. A factor of particular interest was 
abnormalities found in the resting Electrocardiogram (ECG), which was recorded in 1993 as well 
as 1998.   
This study aims to investigate if there are statistical associations between ECG findings and the 
cumulative risk of death and MI as well as how much the information about ECG abnormalities 
(ECGA) adds to that which can be obtained using the well-known Framingham Risk Index (FRI) 
for the risk of MI or death. That is, how much certainty in prediction of these events is gained if 
we know the result of ECG investigations. The study is limited to the Swedish cohort of workers. 
 Methods: The answers to the questionnaire and laboratory data from the health survey at 
baseline (1993) were used to estimate the risk of cardiovascular disease according to Framingham 
Risk Index (FRI) and to obtain information of known riskfactors, some included in the FRI and 
some not. The ECG examinations in 1993 and 1998 were analyzed using the Minnesota Code 
Classification System for Electrocardiographic findings (MC).  In 2018 we obtained information 
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about deaths from the National Board of deaths register for the Swedish participants. In 2019 data 
was collected from the National myocardial infarction registry, Swedeheart. The basic tools for 
the statistical analyse were conventional basic statistical analysis and logistic regression with 
death or MI as the dependent variable. We used five sets of independent, explanatory variables 
(Models1-4 below): 
1. ECG abnormality (ECGA) only 
2. FRI quintiles only (for reference, the ECGA variable not included) 
3. ECGA and FRI quintiles 
4. ECGA and the variables constituting FRI. 
5. As in 3 above with a number of additional variables 
Pseudo-R2 according to McFadden was used to describe the prognostic value of the models. 
Nelson –Aalen curves were used to illustrate the cumulative risk for death and MI.  
Results: Seventy-nine of the 977 participants with baseline information had at least one ECG 
abnormalities 1993 or 1998, 790 participants had two normal ECG, 108 had one normal ECG and 
missed the other ECG examination. Death data showed that 157 participants had died before 
2019. The data from Swedeheart showed that 100 participants had a first MI over the 25 years.  
The Odds ratio (OR) for having a MI in the group that had one or more ECG abnormality 
compared with the group with two normal ECGs (Model 1) was estimated to 3.16 (CI 
(1.74;5.73), p-value 0.000).   
For death no statistically significant difference was shown between the group with at least one 
ECG abnormality and the group with two normal ECG (model 1) OR 1.52 (CI (0.83-2.76).  
 
For MI, Model 1 had a Pseudo-R2 of 2%, Model 2 had 9%, Model 3 had 14 % and Model 4 
reached 25%. The corresponding percentages for death were all lower.  
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Conclusions: 
Our study confirms what other studies have shown i.e. ECG abnormalities are statistically 
associated with increased risk of suffering from an MI but not for death. However, larger studies 
are needed to evaluate the importance of specific types of ECG abnormalities.   
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Introduction: 
The Coeur study started in 1992 in a joint cooperative project between the occupational health 
departments of Renault (France) and Volvo (Sweden) about the French paradox. Data exist from 
1993 (baseline) and 1998 (first follow-up) from 1,000 middle-aged Swedish men and 1,000 
Frenchmen 
 
In the present study we do a follow-up of the Swedish cohort with focus on ECG abnormalities 
and their subsequent associations with myocardial infection (MI) and death for 25 years. 
 
The causes of death vary over time and between countries. In the 1970´s Ancel Keys and 
colleagues followed 11,579 middle-aged men in seven countries for 15 years. Six hundred and 
eighteen (27%) died from coronary heart disease [1].  In 2011, cardiovascular disease (CVD) was 
the main cause of mortality responsible for over 3.9 million deaths a year in Europe, or 45% of 
all deaths, and for 1 of every 3 deaths in the Unites States [2,3]. 
The map of the burden of disease exhibits disparities within and among populations [4].  
In 2015, unadjusted life expectancy was for Swedish men 80.1 years versus 78.8 for Frenchmen 
[5].  
 
Ancel Keys groundbreaking study of seven countries, with populations that varied in relation to 
their physical characteristics and lifestyle was the start of cardiovascular epidemiology. He found 
that atherosclerotic diseases correlated with dietary fat, high blood pressure and smoking [6].  
Consequently, the Monitoring trends and determinants in cardiovascular disease (MONICA) 
collaboration published a comparison of the epidemiology of myocardial infarction (MI) and 
coronary deaths in 21 countries in four continents [7].   
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They confirmed that the annual age standardized coronary event rates of MI for the period 1985-
1987 for men was lower in Mediterranean countries such as France (France, Toulouse) 240/100 
000; 95% CI 225-255 as compared to Nordic countries such as Sweden (Sweden, Gothenburg)  
406/100 000; 95% CI 380-432 [7]. This difference coined the French Paradox because 
Frenchmen with a higher fat consumption (such as cheese), and wine compared to Swedish men 
paradoxically had a lower rate of MIs.  
 
Myocardial infarction 
MI, commonly known as a heart attack, occurs when the blood flow decreases or stops to some 
part of the heart, causing damage to the heart muscle. Most MIs occur due to coronary artery 
disease also called ischemic heart disease [8].   
 
Ischemic heart disease is according to the World Health Organization (WHO) the leading cause 
of death globally (2016) and was responsible for 9.4 millions of death or 16% of all deaths 
worldwide 2016 [9].  Even in Sweden Ischemic heart disease is the leading cause of death [10].  
 
Ischemic heart disease includes stable angina, unstable angina, myocardial infarction, and sudden 
cardiac death [11]. There are different instruments to calculate the risk of cardiovascular events 
using risk factors, for examples SCORE, Qrisk and Framingham Risk Score [12-15]. In 1998 the 
first version of Framingham risk score (FRS), developed from data of the Framingham Heart 
Study was published [16]. It calculates an individual’s 10-years risk for cardiovascular events.  
The Framingham Risk score has been validated for Americans, and subgroups of Americans 
(both gender, European Americans, African Americans) [17].  
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The Framingham Heart study showed several factors associated with increased risk of myocardial 
infarction. These include older age, male sex, high blood pressure, current smoking, abnormal 
lipid levels, diabetes, obesity, and physical inactivity [18].  
 
ECG as risk assessment 
Electrocardiography (ECG) is a common examination in both annual health checks and as a part 
of the diagnostics when patients have suspected symptoms from the heart e.g. chest pain. ECG is 
used as a screening instrument in some profession such as pilots, and train drivers 
ECG is a non-invasive test that measures the electrical activity of the heart beat and also provides 
information about heart muscle damage, types and kinds of arrhythmias and signs of a heart 
attack. 
 
In 2017, a population-based retrospective cohort study in Canada found that ECG taken during 
annual health examinations was common, in 22% [19]. ECG is also used as a screening method 
in some professions (e.g. air pilots) [20]. And there is a plenty of private options for those who 
want to undergo a health check including ECG, e.g. google gives 17 millions hits if you search 
for “private ecg” [21].  
 
In 2018, the US Preventive Services Task Force (USPSTF) published its recommendations on 
screening for cardiovascular disease risk using electrocardiography (ECG). USPSTF 
recommends against screening low risk adult with ECG. For adults with higher risk, they 
conclude that there is insufficient evidence for making a recommendation [22].  
 
The USPSTF submitted a report reviewing the association of ECG and cardiovascular endpoints. 
 11 
Regarding resting ECG, they found 9 cohort studies (n = 66 407) that showed adding a resting 
ECG to traditional risk factors produced small improvements in risk assessment [23] 
 
One cohort study from the Netherlands concludes “Performing a resting ECG in a primary care 
population does not seem to improve risk classification” [24]. 
 
Contrary to this several studies that showed that specific and unspecific ECG abnormalities can 
help predict cardiovascular events, MI and death [25-34].  
Several studies indicate that prolonged QRS-complexes are associated with higher risk for 
MI/Death [25-28, 30].  In the largest of these studies they evaluated the 12-lead ECGs of 10 899 
Finnish middle-aged subjects from the general population and it showed that “Prolonged QRS 
duration predicted all-cause mortality (multivariate-adjusted relative risk [RR] 1.48; 95% 
confidence interval [CI] 1.22–1.81; P<0.001), cardiac mortality (RR 1.94; CI 1.44–
2.63; P<0.001), and sudden arrhythmic death (RR 2.14; CI 1.38–3.33; P=0.002)”[26]. 
 
 In the National Health and Nutrition Examination Survey—III which Included 8,527 patients 
with ECG data they found “The addition of the QRS duration in 10-millisecond increments to the 
Framingham Risk Score model resulted in 4.4% overall net reclassification improvement (95% 
CI 0.02 to 0.04; p = 0.00006). In conclusion, increased QRS duration was found to be an 
independent predictor of CV mortality in this cross-sectional US population. A model including 
QRS duration in addition to traditional risk factors was associated with improved CV risk 
prediction.” [27] 
 
 A few studies show that T-wave inversion is associated with all-cause and cardiac mortality 
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[25,29-31].  In the PRIME Study they recorded 10 600 ECG from men.  Later a study showed 
that Isolated negative T waves (INTW) after multivariate adjustment that “INTW ≥1 mm in 
lateral or anterior leads were associated with a higher incidence of myocardial infarction [HR 
2.75, 95% CI (1.29–5.88) and HR 3.20 95% CI (1.68–6.09) respectively]. The association of 
INTW ≥1 mm in leads V1 to V5 with mortality remained highly significant [HR 3.17 95% CI 
(1.77–5.65)] after multivariate adjustment” [31].  
 
Furthermore some studies show that unspecific as well as any major ECG abnormalities are 
associated with death/CVD/MI in specific patient populations [32-35].   
Among the coding systems for classification of electrocardiographic (ECG) abnormalities, the 
Minnesota Code (MC), introduced in the early 1960s, is the most widely used in epidemiologic 
studies and clinical trials [36-38]. 
 
Volvo, Renault and a study of the French paradox. 
In the beginning of the 90s the two automobile manufacturers Volvo (Sweden) and Renault 
(France) were planning to merge. Both companies’ health care units decided to start a study of 
the French paradox [39]. The question was why myocardial infarction is more common in 
Swedish men than in French, despite the Frenchmen had a less healthy lifestyle, particularly more 
cheese and wine. This query was the basis for a comparative study of middle-aged men at 
Renault and Volvo.  
 
Cardiovascular morbidity is hypothesized to vary with differences in environmental factors, 
individual life style, and diet. The aim of the study was to compare the risk factors of sub-groups 
thereby creating hypotheses about causality. The result would hopefully serve to direct the 
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preventive work of occupational health services. 
 
In 1993 1,000 men between 45-50 years from each company/country were chosen to undergo an 
extensive nurse-led investigation of health including a resting ECG, laboratory samples, and a 
survey with 144 questions. In the baseline questionnaire,the family history of a heart attack 
question was worded: "Before the age of 70, has anyone in your family (parents, sisters, brothers) 
been affected by a heart attack?". The risk for cardiovascular events was calculated by the 
Framingham Risk Index.    
 
In 1995, a special study of pathogenetic mechanisms included ultrasonography of the heart and 
blood vessels, blood viscosity measurements, hormone analyses, and a diet interview was 
performed in sub-groups from the population. These sub-groups were selected to include 90 
individuals with high and 90 with low Framingham Risk Index from each country [40]. 
 
In 1998 a five-year follow-up was performed.  95% of the Swedes and 74% of the French were 
reached for the follow up.  In the Swedish cohort both subjective (self-reported) and objective 
(register verified) end-points were collected. In the French cohort only, subjective end-point were 
collected. A full nurse-lead medical examination including a second ECG was also offered. 
 
The Swedish cohort reported triple the rate of subjective end-points compared to the French. The 
study showed that differences in alcohol intake, female social support, and detection and 
treatment of traditional risk factors might partly explain the national differences of cardiovascular 
end-points in this cohort [41]. 
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The Swedish Cohort     
The merger of Volvo and Renault was never fully accomplished, and after the 5-year follow-up, 
the French cohort was thus not available for any more follow-ups.  This left us with the Swedish 
cohort including 980 Swedes from the baseline available for follow-up. Today (2019) all men 
born between 1943 and 1948 should be between 70-75 years old.  The group were all employees 
at the start of the study, white-collar 61% and blue-collar workers 39%.   
 
In 2015, this cohort was revisited, and incident MIs were identified using postal questionnaires, 
hospital records, and the Swedish national MI and death registers. This study concluded that 
traditional risk factors were confirmed but explained a modest proportion of the risk. The French 
paradox was not contradicted, but the mechanism behind it remains unclear. [42] 
 
The long follow-up period (25 years) and the baseline documentation of a multitude of traditional 
and non-traditional risk factors allow for of the additional risk estimate of ECG-Abnormalities. 
This type of follow up in a relatively healthy male working population will add important 
information on the interpretation of often neglected ECG findings at routine health examinations  
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AIM 
The aims of this study were: 
• To investigate statistical associations between ECG abnormality (ECGA) found in resting ECG 
of healthy Swedish working men aged 45 to 50 years and risk of death or MI during 25 
years. 
• To investigate how much the information about ECG findings adds to that which can be obtained 
using the Framingham index for prognosis of death and MI. Shortly, how much better can 
the prognosis be made if we know about ECG abnormality. 
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Material and methods  
The present study is part of the Coeur project a prospective longitudinal study started in 1993 where 
survey and laboratory baseline data (including a 12-lead ECG) were collected from 1000 randomly 
selected Caucasian men born between 1 January 1943 and 1 January 1948 from two enterprises 
Volvo and Renault. The main goal was to investigate the French paradox – Why Frenchmen have 
less cardiovascular events then Swedes even do the higher burden of risk factors.  [39]    
 
The Swedish cohort from 1993 
In 1993, all Caucasian men born between 1 January 1943 and 1 January 1948 in the participating 
Volvo units were extracted from the personnel files. From this cohort of  about 4000 men, every 
third person from the top of the list down was asked to participate in the study, until 1000 volunteers 
had been selected out of the 1144 men who were approached [41]. Information was obtained by 
extensive laboratory examinations and a self-administered questionnaire. Cardiovascular risk was 
estimated for all participants using the Framingham risk index according to Andersson [43].   The 
formula that was used can be found in appendix 1.   
 
The following baseline data was used for the present analysis: age; married/single/divorced; 
smoking status (Yes/No); systolic blood pressure (SBP) in mmHg; pulse rate in beats/min; serum 
high-density lipoprotein cholesterol (HDL-C) in mmol/L; serum triglycerides (TG) in mmol/L, 
diabetes mellitus; left ventricular hypertrophy; Framingham risk index; alcohol intake in g/week; 
body mass index (BMI) in kg/m2; sagittal abdominal diameter in cm and ECG. 
 
At baseline, all employees completed a self-administrated standardized questionnaire. Marital 
status was categorized as married/single/divorced. Smoking habits were compiled by the question 
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about current smoking (yes/no) defined as “Do you presently smoke” 
 
Registered anthropometric measures, standardization of blood pressure and heart rate 
measurements together with venous blood tests, lipoproteins and ECG are detailed in a previous 
report [39]. 
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ECG collection and analysis 1993 in the Swedish cohort 
The 12-lead resting ECGs and the examinations were performed by two nurses (one in Gothenburg 
and one in Trollhättan). All ECGs were read and coded by the same laboratory technician [39]. The 
ECG investigation was conducted under a strict protocol, developed by professor Sverker Jern.  All 
ECG where classified by The Minnesota Code Classification System for Electrocardiographic 
Findings (MC).  
 
Figure 1: An overview of The Minnesota Code Classification System for Electrocardiographic 
ECG Findings  
The Swedish cohort from 1993 first follow-up and new ECGs in 1998. 
In 1998 step three the Coeur project was performed [40]. All 1000 Swedish participant where 
called in for a new health check-up including a new ECG. The same ECG protocol as the one 
used 1993 was used and each ECG was classified by the same nurse at the department of 
physiology at Östra Sjukhuset according to The Minnesota Code Classification System for 
Electrocardiographic Findings.  
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The 25-year follow-up, end-point information 
In 2019 we contacted The National Board of Health and Welfare (Socialstyrelsen), to gain access 
to the Cause of Death Register and to identify who out of our 1,000 participants had passed away, 
and for what cause according to the ICD manual. 
Furthermore, we contacted the Swedish national myocardial infarction registry, also known as 
Swedeheart to obtain information about heart attacks in our cohort. Swedeheart is a national 
database that was started in 2009 by combining four already existing databases, thus creating the 
largest heart disease registry in Sweden. The registry collects information from all Swedish 
hospitals that care for patients with acute coronary artery disease and all patients undergoing 
coronary angiography, catheter intervention, or open-heart surgery [44]. To define myocardial 
infarction, we used code 410 of the International Classification of Diseases Ninth Revision, and 
codes I21-I23 of the Tenth Revision. 
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Variable definitions 
Outcomes, endpoints (dependent variable):  
Death 157, deaths reported 
First Myocardial Infarctions, 100 MI reported 
 
Explanatory (independent) variables, components of Framingham Risk Index: 
Systolic blood pressure (mmHg) 
Smoking (Yes/No) 
HDL Cholesterol/ Tot Cholesterol  
Left ventricular Hypertrophy  
Age  
Diabetes (Yes/No) 
 
Additional explanatory variables 
Diastolic blood pressure (mmHg) 
Heart rate (beats/min) 
Triglycerides (mmol/l) 
Glycemia (mmol/l) 
Body mass index BMI  
Waist/Hip ratio  
Sagittal diameter (dm) 
Total alcohol consumption (g/week)  
Blu Collar Workers (Yes/No) 
Married or cohabiting (Yes/No) 
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Noisy work environment (Yes/No) 
Hypertension (Yes/No) 
Family heart attack (Yes/No) 
 
STATISTICAL ANALYSIS 
The cumulative incidence from baseline to the end of follow-up was estimated as a percentage 
with confidence limits estimated using the conventional method. Confidence intervals were 
estimated using exact probability methods when requested due to small numbers 
To study the associations between ECG abnormalities (ECGA) and other risk factors by category, 
we used conventional means with confidence limits, again with exact methods when necessary. 
To study different models with the dichotomous variables Death or MI as dependent variable and 
different combinations of risk factors as independent variables, logistic regressions were used. 
All such models except one, included the dichotomous ECGA. One model contained only the 
FRI variable as independent. Continuous variables like FRI, SBP, BMI etc. were represented in 
the model with dummy variables for the five quintiles of the variable distribution 
The results considered in the logistic models were the Odds Ratios (OR) and a Pseudo R2. The 
Odds of an event is the risk for the event divided by 1 minus the risk, i.e. the probability for the 
event divided with the probability for non-occurrence. If the risk is low, we can say that the OR is 
a fair approximation of the Risk Ratio (RR) or relative risk. The estimates of OR are given with 
appropriate confidence intervals. 
The logistic regression uses a generalized linear model. We cannot use the traditional R2 to 
assess the goodness-of –fit of the model. Several Pseudo R2 have been proposed. The one used 
here is the one proposed by (Mc Fadden) [45], that can be interpreted similarly to the R2 for a 
linear model. The Pseudo-R2 results are expressed as percentages in this paper. 
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The Nelson-Aalen curve was used to illustrate the occurrences of death and MI over time. It uses 
the same information as the more commonly used Kaplan-Meier curve and gives the same 
information. The N-A starts from the whole group and shows how individuals leave as events 
occur. The K-M starts from totality and shows what is left at different time points. When the 
incidence of events is low and we don’t want to censor the y-axis the K-M curve(s) do not 
deviate too much from unity and can become problematic to read. The N-A uses the graph space 
more fully.  
 
Calculations were performed using the software Stata version 15.  
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Ethics   
The Research Ethics Committee of Gothenburg University approved the study protocol on 11 
February 1993, and the Swedish Data Inspection on 26 January 1993. The Research Ethics 
Committee of Gothenburg University renewed their approval of a changes study protocol on 19 
February 2019. Applications to the national death registry and Swedeheart were also approved. 
Participation was voluntary, and the partakers could with draw at any time. Data were only 
analyzed at the group level and the participants were anonymized using attributed Id-numbers. 
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Results    
 
The study participants and ECG outcome 
The sample selected for the baseline survey included 1000 men aged 45-50 years. Of these 3 did 
not provide any information. Another 20 had substantial numbers of missing values, particularly 
they did not have results from any of the two ECG investigations in 1993 and 1998. (Table 1) 
Totally 108 participants had only one ECG, 72 in 1993 and 36 in 1998. ECG means 
electrocardiogram. ECGA means electrocardiogram with abnormality. 
 
Table 1. Electrocardiographic abnormalities (ECGA) of the 977 cohort participants, men aged 45-
50, in 1993 (baseline) and at follow up in 1998 
ECG 1993    
ECG 1998 ECGA no ECGA yes Missing Total  
ECGA no 790 29 72 891 
ECGA yes 19 15 7 41 
Missing 36 9 (23)* 45 
Total 845 53 79 977 (1000)** 
 
*  23 non-informative 
**  1000-23 informative 
 
Classification of ECG outcomes 
 
The 977 participants were classified into three ECG categories as follows: 
ECG Category 0     ECG performed 1993 and 1998, no ECGA,                                    (n= 790) 
ECG Category 1     ECG performed 1993 and/or 1998   One or more abnormalities.       (n= 79) 
ECG Category 9     ECG performed 1993 or 1998 without abnormality.                            (n= 108) 
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Table 2. Estimated cumulative incidences (percentages) and absolute numbers of deaths and 
first MI for participants followed for 25 years by category.                                                           (95% 
confidence intervals in brackets) 
 
 
 
ECG 
Category 
Death (n=157) 
Cumulative 
percentage 
 
Infarction (n=100) 
Cumulative 
percentage 
Deaths  
Number of 
cases 
First MI 
Number of 
cases 
0 (n=790) 13.9  (11.5;16.3) 8.35 (6.42;10.3) 110 66 
1 (n=79) 20.8 (11.5;30.0) 22.4 (13.8;31.9) 16 17 
9 (n=108) 27.6 (18.5;36.6) 12.6 (5.83;19.4 27 12 
Total 15.6  
(13.3; 17.57) 
10.2 
(8.3; 12.1) 
153* 95** 
 
*    4 deaths among the 23 non-informative 
**  5 MIs among the 23 non-informative 
 
 
 
Note: ECG Category 0     ECG performed 1993 and 1998, no ECGA                                    
ECG Category 1     ECG performed 1993 and/or 1998 with one or more abnormalities              
ECG Category 9     ECG performed 1993 or 1998 without abnormality                                   
 
 
 
As shown in Table 2 surprisingly the category 9 with only one registered and normal ECG 
compared to category 0 with two normal ECGs had a significantly higher risk of death, but not of 
MI. As expected, category 1 with one or more ECG abnormalities had over double cumulative 
percentage than category 0 
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Table 3. Estimated means with 95% confidence intervals in brackets for continuous baseline risk 
factors by ECG category 
 
Risk factor ECG Category 0 
(n=790) 
ECG Category 1 
(n=79) 
ECG Category 9 
(n=108) 
Framingham risk 
index  
0.089 (0.085-0.093) 0.108 (0.091-0.128) 0.094 (0.080-0.108) 
Systolic blood 
pressure (mmHg) 
116 (115- 118) 124 (120-128) 116 (113- 119) 
Diastolic blood 
pressure (mmHg) 
75 (74-75) 79 (76-83) 74 (71-76) 
Heart rate (beats per 
minute) 
63 (63-64) 63 (61-66) 62 (61-65) 
HDL chol/ total 
cholesterol 
0.212 (0.207-0.216) 0.226 (0.197-0.255) 0.207 (0.193-0.222) 
Triglycerides 
(mmol/l) 
1.52 (1.46-1.58) 1.53 (1.31-1.74) 1.60 (1.38-1.82) 
Glycemia (mmol/l) 
 
5.47 (5.40-5.54) 5.58 (5.27-5.89) 5.39 (5.22-5.57) 
Body mass index 
BMI 
25.8 (25.5-26.0) 25.4 (24.6-26.2) 25.0 (24.4-25.6) 
Waist/hip ratio 
 
0.933 (0.929-0.937) 0.923 (0.910-0.936) 0.930 (0.919-0.941) 
Sagittal diameter 
(dm) 
2.03 (2.02-2.05) 2.02 (1.95-2.08) 1.98 (1.93-2.02) 
Alcohol consump 
(g/week) 
51.5 (47.4-55.6) 52.2 (41.1-63.3) 54.3 (41.7-66.9) 
Note: ECG Category 0     ECG performed 1993 and 1998, no ECGA                                    
ECG Category 1     ECG performed 1993 and/or 1998 with one or more abnormalities              
ECG Category 9     ECG performed 1993 or 1998 without abnormality                                   
 
Table 3 only shows statistically significant differences in higher blood pressure (systolic and 
diastolic) between those with normal ECGs (category 0) and those with ECG abnormalities 
(category 1). 
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Table 4. Estimated percentages of “yes” response, with confidence intervals in brackets for 
dichotomous risk factors by ECG category. 
 
Risk factor ECG Category 0 
(n=790) 
ECG Category 1 
(n=79) 
ECG Category 9 
(n=108) 
Blue collar workers 
 
39 (36-43) 39 (27-50) 36 (26-46) 
Married or 
cohabiting 
77 (74-80) 79 (69-88) 74 (65-83) 
Noisy work 
environment 
3.7 (2.4-5.0) 8.0 (1.7-14.3) 5.3 (0.69-9.83) 
Smoker  
 
28 (25-31) 26 (16-36) 30 (20-39) 
Diabetes at baseline 
 
0.008 (0.001-0.014) 0.039 (0.000-0.084) 0.042 (0.000-0.0832) 
Hypertension at 
baseline 
8.8 (6.79-10.7) 21 (11.6-30.4) 9.5 (3.48-15.4) 
Family heart attack 
 
23 (20.0-25.8) 29 (18.8-39.9) 27 (18.2-36.4) 
Note: ECG Category 0     ECG performed 1993 and 1998, no ECGA                                    
ECG Category 1     ECG performed 1993 and/or 1998 with one or more abnormalities              
ECG Category 9     ECG performed 1993 or 1998 without abnormality                             
 
Table 4 shows a statistically significantly higher percentage of baseline hypertension in those 
with ECGA (category 1) compared to those with normal ECG (category 0). 
 
No statistically significant risk difference between Category 1 and Category 0 was seen for blue 
collar workers (OR =1.02; p=0.93)  
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Regression models 
The results from Logistic regression models are presented in Tables 5 and 6. The two tables have 
identical structure and content. Table 5 gives the results for the estimation in a series of models 
for the outcome, dependent, variable death whereas Table 6 shows the corresponding for the 
outcome “first MI”. 
 
The independent variables in the models 1-5, from top to bottom in the two tables, are: 
1. Category of ECG 
2. Quintiles of the FRI 
3. Category of ECG together with FRI 
4. Quintiles of ECG together with the variables that are included in the FRI, here considered 
separately in linear form. 
5. Quintiles of ECG, the FRI variables in linear form and the additional; total alcohol, Heart 
rate, BMI, Waist/Hip ratio and Sagital diameter.  
 
For the two last models the tables contain only the estimates for ECGA and total model Pseudo 
R2.  
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Table 5. Results for regression models with death as dependent variable with ECGA and 
additional independent variables of the 977 cohort participants of men aged 45-50 at baseline 
in 1993 followed for 25 years 
 
Death 
 
Model 
Independent 
variable(s) 
Estimated 
OR 
95% 
confidence 
interval for 
OR  
p-value 
for OR  
Pseudo-R2 for 
model 
% 
ECGA only 
 
(Model 1) 
ECGA =0 
ECGA =1 
ECGA =9 
Referens 
1.52 
2.09 
 
(0.83; 2.76) 
1.26  3.46 
 
0.106 
0.001 
1.4 
FRI  
Only 
 
(Model 2) 
FRI=1 
FRI=2 
FRI=3 
FRI=4 
FRI=5 
Referens  
0.68 
0.77 
1.51 
2.16 
 
(0.35; 1.31) 
(0.40; 1.46) 
(0.66; 2.67) 
(1.25; 3.73) 
 
0.248 
0.418 
0.154 
0.006 
2.9 
ECGA and 
FRI 
 
(Model 3) 
 
ECGA =0 
ECGA =1 
ECGA=9 
 
FRI=1 
FRI=2 
FRI=3 
FRI=4 
FRI=5 
Referens 
1.58 
1.84 
 
Referens 
0.68 
0.69 
1.40 
2.12 
 
(0.85; 2.93) 
(1.06; 3.20) 
 
 
(0.35; 1.32) 
(0.36; 1.34) 
(0.75; 2.51) 
(1.22; 3.69) 
 
0.146 
0.030 
 
 
0.256 
0.272 
0.246 
0.007 
3.8 
ECGA and 
FRI 
variables 
 
(Model 4) 
ECGA =0 
ECGA =1 
ECGA =9 
Referens 
1.41 
1.84 
 
(0.73; 2.73) 
(1.01; 3.37) 
 
0.301 
0.048 
8.3 
ECGA and 
all 
explanatory 
variables 
 
(Model 5) 
ECGA =0 
ECGA =1 
ECGA =9 
Referens 
1.42 
2.52 
 
(0.69; 3.02) 
(1.27; 4.97) 
 
0.247 
0.021 
13.8 
 
The main interest is the association between death and ECG abnormality. We don’t find a 
statistically significant association in any of the models in Table 5. The lack of statistical 
significance with OR between 1.4 and 1.6 is largely due to the small number of ECGA. The 
significant OR comparing the categories coded 0 and 9 is difficult to interpret since the last 
category is problematically defined. 
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The Pseudo-R2s are generally low even for the largest model (13.8). It shall be noted though, that 
the ECGA variable has some importance. However, even at the low level, the model with ECGA 
and the individual FRI variables is better than the model where the calculated FRI is used.  
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Table 6. Results for regression models with first MI as dependent variable with ECGA and 
additional independent variables of the 977 cohort participants of men aged 45-50 at baseline 
in 1993 followed for 25 years 
 
Infarct 
 
Models 
Independent 
variable(s) 
Estimated 
OR 
95% 
confidence 
interval for 
OR  
p-value 
for OR  
Pseudo-R2 for 
model 
% 
ECGA only 
 
(Model 1) 
ECGA =0 
ECGA =1 
ECGA =9 
Referens 
3.16 
1.59 
 
(1.74; 5.73) 
(0.82; 3.06) 
 
0.000 
0.168 
2.11 
FRI  
Only 
 
(Model 2) 
FRI=1 
FRI=2 
FRI=3 
FRI=4 
FRI=5 
Referens  
6.35 
9.27 
14.3 
25.4 
 
(1.40; 28.8) 
(2.11; 40.7) 
(3.24; 61.5) 
(6.02; 106) 
 
0.017 
0.003 
0.000 
0.000 
8.57 
ECGA and 
FRI 
 
(Model 3) 
ECGA =0 
ECGA =1 
ECGA=9 
 
FRI=1 
FRI=2 
FRI=3 
FRI=4 
FRI=5 
Referens 
2.82 
1.43 
 
Referens 
6.22 
7.98 
14.1 
24.3 
 
(1.51; 5.28) 
(0.70;2.89) 
 
 
(1.36; 28.3 
(1.79; 35.5) 
(3.28; 60.6) 
(5.77; 103) 
 
0.001 
0.324 
 
 
0.018 
0.006 
0.000 
0.000 
10.6 
ECGA and 
FRI 
variables 
 
(Model 4) 
ECGA =0 
ECGA =1 
ECGA =9 
Referens 
3.43 
1.24 
 
(1.74; 6.76) 
(0.57; 2.70) 
 
 
0.000 
0.579 
14.9 
ECGA and 
all 
explanatory 
variables 
 
(Model 5) 
ECGA =0 
ECGA =1 
ECGA =9 
Referens 
4.22 
1.18 
 
(1.85; 9.64) 
(0.47; 2.96) 
 
 
0.001 
0.719 
24.6 
 
For  MI  the OR for comparisons of ECGA=0 and ECGA=1 are all statistically sigmificant whereas 
those comparing ECGA=0 and ECGA=9 are not. ECG investigation is statistically significantly 
associated with MI but not with death. The OR for ECGA are all fairly high, between 2.8 and 4.2, 
regardless of model. 
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The R2s are higher for MI than for death and the model with individual FRI is higher than the 
model with computed FRI, same as for death. The highest R2 is almost 25% which is higher than 
for the 13% for death. Both however, shall be considered as fairly low.   
 
 
The tables 7 and 8  shows the distributions of ECG abnormalities by types according to the 
Minnesota classification”.     
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Table 7 Number of ECG deviations in 1993 Electrocardiographic abnormalities and myocardial infarction and death in 964 middle-
aged, employed men in 1993 followed for 25 years  
Minnesota 
code 
Explanation Investigated   
persons  
Observed  
findings 
Findings 
with 
death  
Findings 
with 
infarct  
p-value 
death         
p-value 
infarct    
ECG findings 
both in 1993 
and 1998 
Q and QS patterns        
1:1 Q and QS pattern  964 3 1 2  .000 2 
1:2 Q , QS and QSR pattern  964 10 1 2   5 
STJ and segment depression        
4:1 or 4:2 STJ depression 947 5 4 3 .000 .000 1 
T wave items        
5:1 or 5:2 T wave negative or biphasic 947 7 3 2 .004 .075 3 
AV conduction defect        
6:1 Complete AV block 964 0      
6:4:1 Wolf-Parkinson-White pattern 964 0      
6:8 Artificial pacemaker 964 0      
Ventricular conduction defect        
7:1:1 Complete left bundle branch 
block  
964 1 0 0   0 
7:2:1 Complete right bundle branch 
block  
964 7 1 2   4 
7:3 Incomplete RBB 964 23 1 5   11 
7:4 Intraventricular block 962 11 4 1 .004  0 
7:6 Incomplete LBB 919 8 1 1    
The p-values refer to death and infarct risk comparisons between persons with and without ECG abnormalities. Only p-values smaller 
than .100 are shown. Note that the p-values themselves are due to variation. Even one single finding more or less might change the p-
value substantially. 
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Table 8 Number of ECG deviations in 1998  Coeur ECG Preliminary results 1998 Follow-up  
Minnesota 
code 
Explanation Investigated 
persons 
Observed 
findings  
Findings 
with 
death 
Findings 
with 
infarct 
p-
value 
death 
p-value 
infarct       
Q and QS patterns       
1:1 Q and QS pattern 944 15 2 3   
1:2 Q , QS and QSR pattern 942 16 1 3   
STJ and segment depression       
4:1 or 4:2 STJ depression 
 
926 18 4 4 .054 .041 
T wave items T wave negative or biphasic       
5:1 or 5:2  
 
924 19 4 5 .072 .006 
AV conduction defect       
6:1 Complete AV block 945 0     
6:4:1 Wolf-Parkinson-White pattern 945 0     
6:8 Artificial pacemaker 945 0     
Ventricular conduction defect       
7:1:1 Complete left bundle branch block 945 1 0 0   
7:2:1 Complete right bundle branch block  945 9 1 2   
7:3 Incomplete RBB 945 26 3 5   
7:4 Intraventricular block 944 4 0 0   
7:6 Incomplete LBB 919 5 1 1   
 The p-values refer to death and infarct risk comparisons between persons with and without ECG abnormalities. Only p-values smaller 
than .100 are shown. Note that the p-values themselves are due to variation. Even one single finding more or less might change the p-
value substantially. 
                          
 36 
Figure 2 Nelson-Aalen Cumulative Risk Estimates for Death by category in 977 men. 
 
Note: ECG Category 0     ECG performed 1993 and 1998, no ECGA                                    
ECG Category 1     ECG performed 1993 and/or 1998 with one or more abnormalities              
ECG Category 9     ECG performed 1993 or 1998 without abnormality  
 
 
The study started in 1993 when the participants were 45-50 years old and finished in 2018, when 
they were 70-75 years old. The Cumulative deaths, all causes, by age at death in category 9 (only 
first ECG) compared to category 1 (first and second ECG with at least 1 abnormal) and category 
0 ( two normal ECGs) indicate that category 9 over the 25 years follow up was at highest risk, 
shown in Figure 2.  
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Figure 3 Nelson-Aalen Cumulative Risk Estimates for MI by category in 977 men. 
 
Note: ECG Category 0     ECG performed 1993 and 1998, no ECGA                                    
ECG Category 1     ECG performed 1993 and/or 1998 with one or more abnormalities              
ECG Category 9     ECG performed 1993 or 1998 without abnormality       
 
 
Contrary to the cumulative deaths and correspondingly Figure 3 shows the significant outcome of 
MIs highest in category 1 (at least one abnormal ECG)                  
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Discussion and analysis  
Main Findings   
A main finding from the present study is that there is a statistically significant difference between 
the cumulative incidences of myocardial infarction (MI) after the 25-year follow-up comparing 
the group of participants that had an ECG abnormality with the group that had not.  The ORs 
quantifying the comparisons are all high, between 2.8 and 4.2, regardless of the regression model 
used. The risk for having an MI is about tripled if there is an ECG abnormality. There is no 
statistically significant assoiation between ECGA and the outcome death. 
 
The US Preventive Services Task Force (USPSTF) in 2018 published a recommendation not to 
use ECG for screening [22].   Our study and others [24-33] though, indicate that using ECG s 
provide some increased information when we estimate a patient's risk of myocardial infarction in 
clinical work. 
 
It is important to realize the difference between using ECG for screening of an assumed healthy 
population and using it as a tool among others in clinical practice. In the former case the USPSTF 
recommendation is justified. Using the present data as an example, a population screening would 
have a sensitivity of about 20% i.e. only one in five will be classified as potential MI patients. 
Further there will be about 75 % false positive, unnecessarily requiring some attention. 
Population screening aims at finding potential cases early and an important requirement also is 
that there is some action that can be taken which is hardly the case in the present study. 
 
In clinical work the assumptions are different with higher sensitivity and less false positive due to 
higher prevalence of persons with really high risk. It can be clinically relevant to examine healthy 
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45-50 years old men with an ECG as one component among others when judging the risk for MI. 
A question though, is how much weight an abnormal ECG shall be given when estimating the 
risk of an MI. Since no specific remedy exists for unspecific ECG abnormalities, such findings 
can mainly be used to emphasize the important prevention of a healthy life-style. This study 
shows that if a professional working man between 45-50 years, has an ECG abnormality, his risk 
of suffering a heart attack is increased more within the next 25 years than if he had not, but it is 
not really possible to say how much.  
 
Due to the few cases in the subgroups of the ECG abnormalities it is not meaningful to evaluate 
statistically the impact of most Minnesota code subgroups on the specific risk. Earlier studies 
suggest that prolonging QRS complexes [25-28+30] and negative T-waves [25,29-31] lead to 
increased risks.   In table 7 and 8 we study this in our cohort. That this cohort is too small for this 
kind of stratification. Even though some p-values are smaller than 0.05, it shall be noted that the 
p-values themselves are due to variation. Even one single case more or less might change the p-
value substantially. 
 
Our results are in line with previously findings that some specific ECG abnormalities are 
associated with increased risk for MI but no increased risk of death. This applies to both 
widespread QRS complexes and negative T-waves. In addition, we also find that STJ depression 
shows an increased risk for both death and MI. 
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Prolonged QTc (pulse-corrected QT-time) has been seen to be associated with higher risk of MI 
and death [46-49]. Prolonged QTc is not classified in the Minnesota code and has therefore not 
been studied here. 
 
Regarding the second aim, finding out what value information about ECGA has compared to the 
Framingham risk index information, it is clear that there is a some added value. This may be 
interpreted so that the mechanism creating the ECGA does not follow the same arteriosclerotic 
mechanism as the FRI. On the other hand, only a small proportion of the infarct risk variations 
are explained by FRI (Psuedo-R2 8.6 %). 
 
We also see in the in the regression models of MI, OR for ECGA are between 3-4 compared with 
normal ECG with small p-numbers and this might suggest ECG abnormalities have a prognostic 
value in identifying risk patients for myocardial infarction.  All OR are over 2.8 when comparing 
those with at least one ECGA registered at either of the two screening occasions compared with 
the reference group with normal ECGs.   However, the Pseudo-R2 for ECGA was only 2.1% 
compared to Framingham risk index (FRI) that had 8.5%. The model combining ECGA and FRI 
has a Pseudo-R2 at 11%.  The Pseudo-R2 values in general are fairly low even if  the ECGA adds 
risk-information in all the modules [Table 6].  
 
The strength of this finding can be questioned when Pseudo-R2 is only 2.1%, but it must of 
course be stated that even the Framingham’s risk score only shows a Psudo-R2 of merely 8.6 % 
and compared with any of the six variables included variables in Framingham Risk Score a 
Psuedo-R2 at 2.1% seems pretty good.   
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Other findings 
An unexpected finding was that ECG the Category 9 participants,  one ECG without abnormality, 
had a statistically significantly higher risk of death, 28% vs 14%. We have no satisfactory 
explanation for this. One thought was that if this could have been a cause of death between -
93 and -98 (the two examinations) but as you see in fig 2 (Nelson) this is not the 
explanation.  Some participants abstaining from the second follow up may have been skeptical 
or lacked confidence in the individual use of the study.However, this can only be a speculation. 
In the regression models of death, Category 9 is associated with significantly higher odds ratio 
then Category 1, the p-value  is less than 0.048 for all the modules. 
 
Another finding shown in table 5 and 6 is that there is more information found in the variables 
included in FRI if they are studied separately then in the combined risk index (FRI).  The Pseudo-
R2 for MI goes from 11% to 15% and for death 3.8% to 8.3%. This suggests that the various 
adjustment factors used in the index are not fully appropriate for the participants of this particular 
cohort. The FRI is calculated using constants from some original data in a specific context and 
therefore be less appropriate in another context.  
Study strengths 
The original 1000 men were randomly selected from a well-defined population. Very few rejected 
to participate. Careful training and supervision of the field work at the baseline survey was secured. 
The procedures for baseline information acquisition was designed using carefully tested 
approaches. Accurate information about end-points is available in Sweden. The registers providing 
end-point information, deaths and MI, come from well-established official institutions that can be 
considered to contain valid data. The internal validity of the study and its results have throughout 
been carefully secured. 
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Study Limitations  
The external validity i.e. validity for other populations and with other contextual structures is 
clearly limited. The study is confined to males in a certain age range in a particular industry and a 
particular country.  The comparable small sample size and, as a consequence, the small number 
of outcomes events is limited is a problem to some extent. 
The study was also limited by the use of the Framingham risk index in the original Coeur study. 
The Framingham risk index has since been superseded by better predictive tools such as QRISK2 
[50] and the use of biomarkers [51], but in a 25-year longitudinal study the analysis is necessarily 
restricted to the original risk measure. Another limitation is that the Minnesota Code doesn’t 
register QTc.  
 
Confounding  
The main research question concerns the statistical association between risk and result of ECG-
investigation. This association can be confounded by several variables. Many of these were 
observed at baseline e.g. age, smoking status, alcohol consumption, weight, height and systemic 
blood measurements. Most of these are correlated each other and with the risk. Therefore, the 
crude correlation between risk and ECG is confounded by a manifold of variables. Among these 
some are known and possible to observe. Others are known but not possible to observe and yet 
others have not even been imagined. The first mentioned group can be adjusted for using 
different regression models. For this paper we have tried several models. An important finding is 
that the OR for ECG abnormality remains reasonably stable, OR about 3 – 4, regardless of model. 
This is an indication that the main results are not seriously confounded by the variables used in 
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the study.  
 
 
Bias   
A bias is a systematic error that has similar size and direction for a group of measurements 
Several biases could influence the results. For example, laboratory results might be biased due to 
incorrect calibrations, questions for self-reporting can be formulated to give biased information. 
Avoidance of bias is a matter of careful planning and testing of the equipment and questionnaires. 
Once data has been collected little can be done about biases.  
 
In longitudinal studies it is possible for both confounding and biases to occur since it is difficult 
to account for changes in individual's habits or health status over the whole, in this case 25-year, 
period. Confounding factors in this study would include not accounting for the eventuality that 
participants’ behaviors might change over time, for example smoking less or loss of weight as 
well as medical treatment of cholesterol and hypertension making the prognostic value of 
baseline risk factor obsolete in some cases. This has been seen in existing studies [50], which 
show secular changes (smoking less, lower cholesterol but higher BMI and sedentary lifestyle) in 
cardiovascular risk factors over time (50 years). Although we do not have secular longitudinal 
data of a 50-year period the findings presented in [52] are likely to be applicable to our cohort. 
Furthermore, another confounding factor could be the addition of medication during this period, 
which may have changed the prognosis of some endpoints. 
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Conclusions 
The study showed that there was an about 3 to 4-fold risk for MI in persons with at least one 
ECG abnormality (ECGA) compared with those with normal ECGs found in resting ECGs of 
healthy Swedish working men aged 45 to 50 years and MI over the following 25 years observed. 
A parallel statement for death could not be made. 
 
Information about ECG findings adds some information of MI risk variation to that which can be 
obtained using the Framingham Risk Index only, thus bettering the prognosis for MI. 
 
The highest Pseudo-R2 observed in the study is found for a MI model with about 20 independent 
variables. It reaches almost 25%, however meaning that we must assume that there is still a large 
number of variables, not observable or totally unknown that influence the risks.   
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Populärvetenskaplig sammanfattning på svenska.  
Bakgrund: I ett medicinskt samarbetsprojekt mellan Volvo (Sverige) och Renault (Frankrike) 
som inleddes 1992 undersöktes 1000 slumpmässigt utvalda anställda män från vartdera land i 
åldern 45–50 år med frågeformulär och en stor hälsoundersökning inklusive omfattande 
laboratorieprover och Elektrokardiogram (EKG). Kända riskfaktorer klassificerades bl.a. enligt 
Framinghams riskindex (FRI) som är ett sammanvägt riksmått grundad på traditionella 
riskfaktorer såsom blodtryck, kolesterol, rökning, övervikt mm. Vid en uppföljning 1998 
noterades alltför få personer med hjärt-kärlsjukdom eller död för att kunna genomföra en 
meningsfull statistisk analys avseende riskfaktorernas betydelse. Samarbetet mellan Volvo och 
Renault har sedan dess upphört Vi har emellertid tillgång till den svenska gruppens data. 
Syfte & Medicinsk relevans:  Hjärt-kärlsjukdom var 1993 den ledande dödsorsaken i världen 
totalt såväl som i Sverige. Vår arbetsfrågeställning var; vilken prognostisk betydelse har en EKG 
avvikelse för att drabbas av hjärtinfarkt och död inom 25 år? Hur förhåller sig denna skattade risk 
till risken som vi uppskattat enbart med hjälp av FRI?  
Vetenskaplig frågeställning: Det finns betydande stöd i litteraturen för att vissa specifika EKG 
avvikelser från det normala är associerade med högre risk för att drabbas av plötslig död och 
hjärtinfarkt.  I en longitudinell studie av friska medelålders arbetsföra män har vi nu haft 
möjlighet att studera associationen mellan en EKG avvikelse observerad i ett EKG tagit i vila och 
hjärtinfarkt eller död inom 25 år. Vi har även möjlighet att studera hur mycket information som 
en EKG avvikelse tillför till riskskattningen som kan skattas med hjälp av FRI. 
Metod: År 1993 insamlades data med hjälp av frågeformulär, Lab-prover och en hälso-
undersökning inklusive ett vilo-EKG. Risken för hjärtkärl-sjukdom uppskattades med hjälp av 
FRI, man samlade även in information om andra kända riskfaktorer som inte ingår i FRI.  År 
1998 vid en första uppföljning togs ytterligare ett vilo-EKG på alla deltagare. Alla EKG 
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klassificerades med hjälp av Minnesota EKG kod (The Minnesota Code Classification System for 
Electrocardiographic Findings).  Data gällande dödfall samlades in från Socialstyrelsens 
dödsorsaksregister och data gällande hjärtinfarkter samlades in från hjärtinfarktregistret 
(Swedeheart).   
Resultat och Analys: Sjuttionio av de 977 deltagarna i studien hade minst en EKG-avvikelse 
1993, 1998 eller vid båda tillfällena, 790 hade två normala EKG, 108 hade ett normalt EKG men 
missade en av undersökningarna. Data från dödsorsaksregistret visade att 157 av deltagarna hade 
avlidit under uppföljningsperioden, 25 år. Data från hjärtinfarktregistret visade att 100 personer 
drabbats av sin, så vitt känt, första hjärtinfarkt. Risken att drabbas av en hjärtinfarkt givet minst 
en EKG-avvikelse är tre gånger så stor som risken utan sådan.  
Inga signifikanta skillnader ses mellan gruppen med en eller flera EKG-avvikelser och gruppen 
med två normala EKG avseende död, däremot observerar man att i gruppen med en missad EKG 
undersökning är risken för död grovt sett dubblerad (Oddskvot =2.35, P-value=0.001). Vår studie 
konfirmerar det andra studier visat att EKG avvikelser verkar ha en prognostisk betydelse för 
risken att få en hjärtinfarkt men fler och större studier krävs för att förstå hur stor riskökningen är 
och hur den ska användas kliniskt.  I vår studie på arbetande medelålders män är risken större än 
vad andra studier visat och oberoende av andra kända traditionella riskfaktorer som högt 
blodtryck, övervikt och höga blodfetter. Då ingen behandling av orsakerna till flertalet EKG 
avvikelser finns, är det av största vikt att förbättra livsstil och behandla kända traditionella 
riskfaktorer för att i denna grupp förebygga hjärtinfarkt. 
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Appendix 1  
  
Framingham risk index was calculated in steps according to Andersson (1991).  The  
formulae used were:  
  
A= 11.11220.9119 * LOG(A169)0.2767 * A400.7181- LOG(A175/A176)  0.5865 *  
POLVH  
M = A1.4792 * LOG(A4)0.1759 * A84;  
MU = 4.4181 + M;  
SIGMA = EXP( 0.3155  0.2784 * M);  
U= (LOG(10)  MU)/SIGMA;  
RISKINDEX = 1  EXP(EXP(U));  
  
Where:  
A169 = systolic blood pressure  
A40 = smoking  
A175 = total cholesterol  
A176 =_HDL cholesterol  
POLVH = possible left ventricular hypertrophy   
A4 = age  
A84 = reported diabetes   
  
(natural logarithms)  
  
 
